FDA — authorised 8 June 1984
- Application: NDA018760
- Marketing authorisation holder: TWI PHARMS
- Local brand name: TENORETIC 100
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Tenoretic 100 in United States
FDA authorised Tenoretic 100 on 8 June 1984
Marketing authorisations
FDA
- Status: approved
Tenoretic 100 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Tenoretic 100 approved in United States?
Yes. FDA authorised it on 8 June 1984; FDA has authorised it.
Who is the marketing authorisation holder for Tenoretic 100 in United States?
TWI PHARMS holds the US marketing authorisation.